Cargando…
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
AIMS/HYPOTHESIS: The aim of this work was to assess the role of well-established cardiovascular risk factors in the late-life cognitive decline of patients with type 2 diabetes. METHODS: Data from 831 participants (aged 60–75 years) attending the 4 year follow-up of the Edinburgh Type 2 Diabetes Stu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473016/ https://www.ncbi.nlm.nih.gov/pubmed/25847351 http://dx.doi.org/10.1007/s00125-015-3581-0 |
_version_ | 1782377168006807552 |
---|---|
author | Feinkohl, Insa Keller, Markéta Robertson, Christine M. Morling, Joanne R. McLachlan, Stela Frier, Brian M. Deary, Ian J. Strachan, Mark W. J. Price, Jackie F. |
author_facet | Feinkohl, Insa Keller, Markéta Robertson, Christine M. Morling, Joanne R. McLachlan, Stela Frier, Brian M. Deary, Ian J. Strachan, Mark W. J. Price, Jackie F. |
author_sort | Feinkohl, Insa |
collection | PubMed |
description | AIMS/HYPOTHESIS: The aim of this work was to assess the role of well-established cardiovascular risk factors in the late-life cognitive decline of patients with type 2 diabetes. METHODS: Data from 831 participants (aged 60–75 years) attending the 4 year follow-up of the Edinburgh Type 2 Diabetes Study (ET2DS) were used. Smoking history (pack-years), BP, HbA(1c), plasma glucose and cholesterol were determined at baseline clinics (single time measurements) and/or from serial data recorded on a clinical management database from diagnosis until recruitment (‘historical’ data). Principal component analysis derived a factor, g, of general ability from seven cognitive tests. Linear regression models of follow-up g were adjusted for baseline g to represent 4 year cognitive change. ‘Accelerated late-life cognitive decline’ was defined as scoring in the lowest tertile of ‘4 year cognitive change’ regression scores. Analyses controlled for age and sex. RESULTS: A baseline history of moderate/heavy smoking (≥10 pack-years) and a 1% increased historical HbA(1c) (equivalent to an increase by 11 mmol/mol) predicted a 64% (OR 1.64; 95% CI 1.14, 2.34; p = 0.007) and 21% (OR 1.21; 95% CI 1.00, 1.45; p = 0.046) increased risk of accelerated cognitive decline, respectively. When treated as continuous measures, higher pack-years, historical HbA(1c) and historical BP emerged as significant independent predictors of 4 year decline in g (standardised β range −0.07 to −0.14; all p ≤ 0.05). CONCLUSIONS/INTERPRETATION: Increased smoking and poorer glycaemic control (with relatively weaker findings for BP) during the life-course were independently associated with accelerated late-life cognitive decline. Where possible, evaluation is warranted of these risk factors as targets for intervention to reduce the burden of cognitive impairment in diabetes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-015-3581-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-4473016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-44730162015-06-22 Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes Feinkohl, Insa Keller, Markéta Robertson, Christine M. Morling, Joanne R. McLachlan, Stela Frier, Brian M. Deary, Ian J. Strachan, Mark W. J. Price, Jackie F. Diabetologia Article AIMS/HYPOTHESIS: The aim of this work was to assess the role of well-established cardiovascular risk factors in the late-life cognitive decline of patients with type 2 diabetes. METHODS: Data from 831 participants (aged 60–75 years) attending the 4 year follow-up of the Edinburgh Type 2 Diabetes Study (ET2DS) were used. Smoking history (pack-years), BP, HbA(1c), plasma glucose and cholesterol were determined at baseline clinics (single time measurements) and/or from serial data recorded on a clinical management database from diagnosis until recruitment (‘historical’ data). Principal component analysis derived a factor, g, of general ability from seven cognitive tests. Linear regression models of follow-up g were adjusted for baseline g to represent 4 year cognitive change. ‘Accelerated late-life cognitive decline’ was defined as scoring in the lowest tertile of ‘4 year cognitive change’ regression scores. Analyses controlled for age and sex. RESULTS: A baseline history of moderate/heavy smoking (≥10 pack-years) and a 1% increased historical HbA(1c) (equivalent to an increase by 11 mmol/mol) predicted a 64% (OR 1.64; 95% CI 1.14, 2.34; p = 0.007) and 21% (OR 1.21; 95% CI 1.00, 1.45; p = 0.046) increased risk of accelerated cognitive decline, respectively. When treated as continuous measures, higher pack-years, historical HbA(1c) and historical BP emerged as significant independent predictors of 4 year decline in g (standardised β range −0.07 to −0.14; all p ≤ 0.05). CONCLUSIONS/INTERPRETATION: Increased smoking and poorer glycaemic control (with relatively weaker findings for BP) during the life-course were independently associated with accelerated late-life cognitive decline. Where possible, evaluation is warranted of these risk factors as targets for intervention to reduce the burden of cognitive impairment in diabetes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-015-3581-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2015-04-07 2015 /pmc/articles/PMC4473016/ /pubmed/25847351 http://dx.doi.org/10.1007/s00125-015-3581-0 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Feinkohl, Insa Keller, Markéta Robertson, Christine M. Morling, Joanne R. McLachlan, Stela Frier, Brian M. Deary, Ian J. Strachan, Mark W. J. Price, Jackie F. Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
title | Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
title_full | Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
title_fullStr | Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
title_full_unstemmed | Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
title_short | Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
title_sort | cardiovascular risk factors and cognitive decline in older people with type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473016/ https://www.ncbi.nlm.nih.gov/pubmed/25847351 http://dx.doi.org/10.1007/s00125-015-3581-0 |
work_keys_str_mv | AT feinkohlinsa cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT kellermarketa cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT robertsonchristinem cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT morlingjoanner cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT mclachlanstela cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT frierbrianm cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT dearyianj cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT strachanmarkwj cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes AT pricejackief cardiovascularriskfactorsandcognitivedeclineinolderpeoplewithtype2diabetes |